March 18, 2019 / 5:17 PM / 8 months ago

Virbac 2018 operating profit grows helped by U.S. market

(Reuters) - French veterinary pharmaceutical company Virbac said 2018 operating profit before depreciation of assets arising from acquisitions grew by 9.6 percent, helped by a strong performance in the U.S. and all other countries except Chile.

Virbac, which sells animal medicines in more than 100 countries, added that the growth came despite a negative currency impact of 7.1 million euros.

The company expects its 2019 operating profit to revenue ratio to increase by around 1 point at constant exchange rates compared to 2018, it said on Monday.

Reporting by Anna Rzhevkina; Editing by Kirsten Donovan

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below